Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-27

FDA Tentative Approval: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA has issued tentative approval for Macleods Pharmaceuticals' generic fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension under ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG TA for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)